Sysmex America celebrated its Top Ten in July with two anniversaries and a milestone
achieved in Insight™
interlab quality assessment program. Sysmex’s theme, Others Talk – Sysmex Delivers
was chosen as exemplifying the achievements of the past decade and the goals for
another successful decade.
In 2003, Sysmex established its U.S. subsidiary and set its sights on driving profitable
growth in the company’s largest market based on a robust portfolio of hematology,
urinalysis and information solutions that uniquely address clinical performance,
efficiency and integration of systems. At that time, market share and awareness
and understanding of Sysmex in the US and Canada was low. Over a decade of operation,
we have made a remarkable ascent to the top of the diagnostics market.
“In 2003, many in the industry did not even know who we were and the leading competitors
were entrenched. Breathtaking changes resulting from healthcare reform were taking
root,” said John Kershaw President and Chief Executive Officer, Sysmex America,
Inc. “Despite these challenges, in just 10 years we have emerged as a formidable
diagnostics market leader and have earned the respect and loyalty of our customers,
including 9 of the top 10 America’s Best hospitals, who have come to know Sysmex
for our unsurpassed reliability, integrated automation, technological advancements
and clinical excellence.”
During this time, Sysmex has grown from a little known company to one that has captured
the #1 US position in CBC testing with a 44% market share as of year-end 2012. Sysmex
is now the number one analyzer under consideration by labs for acquisition in the
next 12 months, according to an Information Dynamics Hematology MARKET MONITOR™
survey, and is the manufacturer that customers consider most likely to meet their
future purchase expectations.
“How did we do this?”, asked Kershaw. “First, we believed it was possible. From
that point on, it was a matter of good people, hard work, a commitment to R &
D, and our commitment to try to answer the question, ‘How is the clinical laboratory
going to evolve over the years to come, and how do we deliver solutions to traditional
and emerging lab challenges?’”
There is much more to expect from Sysmex in the next 10 years and beyond. This includes
delivering two new products which made their debut at this year’s AACC annual meeting;
the Sysmex DI-60™ Integrated Cell Image Analyzer, the first differential module
designed to be fully integrated into the new Sysmex® XN-Series Automated
Hematology Systems, and the Sysmex XP-300™ Automated Hematology Analyzer for smaller
labs. Soon the latest version of the company’s hematology-specific middleware software,
Sysmex WAM™ v5.0, will enable laboratories to further expand the efficiency and
control over their hematology workflow and results management. These three products
demonstrate the commitment by Sysmex to continually re-invent proven technology
and deliver solutions that meet the needs of the ever evolving clinical lab environment.
Even so, our work is just beginning. We will continue our rich Sysmex heritage in
research and development by opening our company’s R & D Americas headquarters
at Sysmex America’s Mundelein, IL campus. The center’s projects will focus on finding
and developing innovative technology to address the future of personalized and preventative
medicine and meet head-on the challenges of healthcare delivery. The new R&D
Americas will remain true to Sysmex’s corporate mission – advancing healthcare,
while doing so with flexibility, individual competence and unsurpassed teamwork.
To learn more, see the article entitled “Introducing
the DI-60 Integrated Slide Processing System” in this issue of Sysmex
John Kershaw receives acknowledgement of the 10th Anniversary
of Sysmex America, Inc. from Ramachandra
Villivalam, representing The Honerable Bradley Schneider, Representative of Congressional
District #10, Illinois.
The 10th anniversary of Sysmex America is also the 10th anniversary of Sysmex WAM™
Decision Support Software for the Clinical Laboratory. Intelligent Automation fuses
informatics, Sysmex WAM, with Sysmex hematology solutions to optimize quality and
efficiency and to measurably reduce allocated resources and operating costs.
Simply put, WAM shifts workload from technologists to technology. Used by nearly
800 labs and healthcare facilities in the U.S. and Canada, this hematology-specific
middleware is helping labs get the utmost performance from their Sysmex automation
solutions by enabling rules-driven auto-validation, management reporting and paperless
As we celebrate our anniversaries, a new version of the WAM Decision Support Software
for the Clinical Laboratory was exhibited at the AACC. WAM v.5.0 includes an extended
delta and previous checking module that goes beyond the traditional delta checking
by adding the ability to lookback and determine the absence or presence of flags,
comments and operator alerts over a range of results. The ultimate goal is to reduce
the number of unnecessary smear reviews or manual differentials, and the system
truly elevates the multi-variable checking for both Delta and Previous data checks.
In addition, Sysmex is previewing expanded support services that will provide automated
rule and workflow testing services for Sysmex WAM customers during implementation.
To learn more, see the article entitled “Improve
your Experience with Information Management
” in this issue of Sysmex
As Sysmex America celebrates its 10th anniversary, we are also pleased to announce
an enrollment of 10,000 analyzers from the US, Canada and throughout Latin America.
During the time that Sysmex has offered Insight
hematology labs have seen many changes in quality control (QC) management. Early
on, data was received by the Insight center on floppy discs sent via U.S. mail by
each lab for each analyzer. Then Insight
gave labs the ability to upload data directly from a floppy disc. The next big advance
was to upload QC without first saving it to a disc by using SNCSTM to manage the
data transmission. The XN-Series now offers the added convenience of automatically
transferring QC data directly to the Insight
data center. In the last ten years, QC data handling has come a long way.
The changes in Insight
follow other laboratory trends. In 2002 there were more participating individuals
registered in Insight
there were analyzers. This reflected the high number of labs where multiple technologists
would run a single standalone analyzer. Since 2005, the increase in the number of
enrolled analyzers has outpaced the number of registered participants. Now fewer
technologists are responsible for QC on more and more analyzers. This reflects the
trend toward laboratory consolidation and the need to have multiple analyzers to
handle the increase in testing that accompanies the aging US and Canadian populations.
As a result of this trend, Insight
added a parent-child relationship to laboratory enrollment in 2010. This allows
a QC specialist at a core lab to use a single log in to access
records for multiple labs. The expansion of Integrated
Healthcare Networks and the growth in commercial reference lab testing have been
significant drivers of this trend.
Since 2005, there have been more analyzers than participants
reflecting the trend of consolidation of lab testing.
The last 10 years has seen other significant improvements:
- The log in for Insight
was made universal. A single log in name and password gives the operator access
to Insight, the CRC libraries, and the ongoing Sysmex webinar program.
- 3-part differential analyzers were added to the
Insight program to standardize reporting for labs of all sizes.
- The ability to add notes to QC runs was added to record observations about data
- The initiation of QC management allowed users of all Sysmex analyzer models to exclude
data by run and preserve the integrity of the data and reports.
- Auto-notification automatically alerts operators to data runs that fall far out
from the expected range of data. This allows the operator to review and exclude
extraneous data points before the period reports are final, resulting in a more
relevant and useful data report.
As the number of enrolled analyzers reached critical mass, Sysmex was able to launch
both Remote Calibration and Evidence-Based Calibration programs. These approaches
to calibration save time, minimize disruptions of work and help optimize analyzer
performance. In addition, the Sysmex XN-Series now takes data handling to a new
level. On all XN-Series analyzers, QC data is automatically transferred to Insight as it is run, with the option
to exclude extraneous data.
Perhaps that is why, of all the Sysmex services,
Insight ranks highest in customer satisfaction surveys with
a 9.3 on a scale of 1 – 10. The dedicated staff at the Sysmex assay lab and data
center makes it their mission to ensure that
Insight will continue to evolve with Sysmex America and with
On July 17-19, 2013 Sysmex exhibited the new Sysmex XN-1000™, XN-2000™ and XP-300™
hematology analyzers for the first time in Brazil at the 40th Brazilian Congress
on Clinical Analysis.
Sysmex staff demonstrated the operation and modularity
of the XN-2000.
With high performance, expandability and advanced clinical parameters, the XN-Series
brings modern solutions for laboratories seeking a new concept in hematology. “We
had the opportunity to demonstrate the innovative technology of the XN-Series analyzers
and how these new analyzers will reshape hematology with their new and unique features.
The client response has been very positive and we believe that the XN-Series will
exceed expectations of performance and modularity,” says Fernando Gatz, Marketing
Manager at Sysmex Latin America and the Caribbean.
The new Sysmex XP-300 hematology analyzer with 3-part differential technology was
also exhibited at this meeting.
This new analyzer combines strength and quality tradition with updated features
such as touch screen, new software
and a unique design.
As a major sponsor of the Brazilian Congress on Clinical Analysis, Sysmex traditionally
sponsors the main scientific presentation of the meeting. The presentation this
year was delivered by a well known professional in the hematology field, Helena
Grotto, MD, PhD. Her presentation “Laboratory diagnosis beyond the CBC: the use
of new profiles as aids in identification of hematological disorders”, was attended
by over 500 people. Dr. Grotto is currently serving as Sysmex Medical Advisor in
Interest in the XN-2000 was high at the Brazilian Congress
on Clinical Analysis.